Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2686 Results
Drew Weissman and Katalin Karikó receive 2021 Lasker Award
Drew Weisman and Katalin Kariko wear masks in a lab and look at liquid in a test tube.

mRNA scientists Drew Weissman, the Roberts Family Professor of Vaccine Research in Penn’s Perelman School of Medicine, and Katalin Karikó, an adjunct professor of neurosurgery at Penn and a senior vice president at BioNTech. (Image: Courtesy of Penn Medicine)

Drew Weissman and Katalin Karikó receive 2021 Lasker Award

Weissman and Karikó’s mRNA technology is recognized for enabling rapid development of highly effective COVID-19 vaccines

Alex Gardner

Imaging technology maps cells tied to inflammatory bowel disease
Microscopic multicolor image of a colon.

Multicolor image of a colon from a patient with ulcerative colitis stained by imaging mass cytometry. (Image: Courtesy of Ayano Kondo from the Kaestner Lab)

Imaging technology maps cells tied to inflammatory bowel disease

“Imaging mass cytometry” shows how cells tied to inflammatory bowel disease affect intestinal tissue, generating new theories for the progression of Crohn’s disease and ulcerative colitis.

From Penn Medicine News

How a diversity program enabled a childhood orthopaedics patient’s research dreams
Doctor holding up an X-ray of a spine in front of a patient, seated.

How a diversity program enabled a childhood orthopaedics patient’s research dreams

The McKay Orthopaedic Research Lab’s Diversity, Equity, and Inclusion (DEI) committee’s conference grant program offers a welcoming environment and resources that support people of all identities, to engate in orthopaedic research.

From Penn Medicine News

Test predicts which patients with rare blood disease will respond to treatment
Person in a white lab coat standing at a lab bench looking at a book. Scientific materials are on the table next to and above the person.

David Fajgenbaum is an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and associate director of patient impact in the Penn Orphan Disease Center. He also leads the Castleman Disease Research Program.

Test predicts which patients with rare blood disease will respond to treatment

A Penn Medicine study identifies blood proteins that indicate which patients with idiopathic multicentric Castleman disease are most likely to benefit from the only FDA approved treatment for the disease, and uncovers an alternative.

From Penn Medicine News

mRNA COVID-19 vaccines induce T-cell responses in multiple sclerosis patients
Person in full PPE administering a vaccine to another person sittting on a hospital bed.

mRNA COVID-19 vaccines induce T-cell responses in multiple sclerosis patients

Research from Penn Medicine shows mRNA COVID-19 vaccines are effective at inducing T-cell responses in multiple sclerosis patients who receive B cell-depleting Infusions even if their antibody responses are diminished.

From Penn Medicine News

Deborah J. Culley on her vision for the future of Anesthesiology and Critical Care
Deborah Culley standing by a railing at the Perelman School of Medicine in a white lab coat.

Deborah J. Culley, chair of the Department of Anesthesiology and Critical Care. (Image: Penn Medicine News)

Deborah J. Culley on her vision for the future of Anesthesiology and Critical Care

Culley discusses her past research on the connection between anesthesia and post-operative cognitive dysfunction and her new role as chair of the Department of Anesthesiology and Critical Care.

From Penn Medicine News

In hard-hit neighborhoods, Philly CEAL outreach aims to address COVID disparities
A person in a mask holding a clipboard at the bottom of steps outside a home. On the porch are an unmasked adult and two unmasked children.

Image: Courtesy of Penn Medicine Service in Action

In hard-hit neighborhoods, Philly CEAL outreach aims to address COVID disparities

Through community engagement and improved information dissemination, researchers at Penn Nursing, Penn Medicine, and Annenberg, in conjunction with the City of Philadelphia, are working to increase vaccination and testing rates and decrease new COVID-19 infections.

Michele W. Berger